Loading...

The Scientist

» BRCA2

Most Recent

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.

0 Comments

image: Genetic Risk Factors for Breast Cancer Identified

Genetic Risk Factors for Breast Cancer Identified

By Ashley P. Taylor | October 23, 2017

Researchers identify 72 novel genetic variants associated with breast cancer risk.

0 Comments

image: Q&A: Sequencing Newborns

Q&A: Sequencing Newborns

By Tracy Vence | October 21, 2016

Members of the BabySeq Project discuss trial enrollment, preliminary findings.

1 Comment

image: BRCA Breakthroughs?

BRCA Breakthroughs?

By Jenny Rood | April 21, 2015

Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.

0 Comments

image: <em>BRCA</em> Mutations Mapped

BRCA Mutations Mapped

By Tracy Vence | April 7, 2015

In a large study, researchers find evidence to suggest that the type and location of a woman’s BRCA1/2 mutations may affect her cancer risk.

0 Comments

image: Yet Another Lawsuit over Genetic Tests

Yet Another Lawsuit over Genetic Tests

By Tracy Vence | June 17, 2014

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

0 Comments

image: Speaking of Science

Speaking of Science

By The Scientist Staff | August 1, 2013

August 2013's selection of notable quotes

0 Comments

image: Another Lawsuit over Genetic Tests

Another Lawsuit over Genetic Tests

By Kate Yandell | July 11, 2013

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.

0 Comments

image: Gene Patents Decision: Everybody Wins

Gene Patents Decision: Everybody Wins

By Jeffrey M. Perkel | June 18, 2013

Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.

4 Comments

Popular Now

  1. Salk Institute Suspends Cancer Scientist Inder Verma
  2. Long-Term Study Reveals Flip in Plant Responses to Carbon Dioxide
  3. Jim Bridenstine Confirmed to Lead NASA
  4. RNA Injection Restores Hearing in Guinea Pigs